Tirzepatide targets both GIP and GLP-1 receptors. Prescribed at REVRCEL in compounded form to a patient-specific prescription by licensed compounding pharmacies, with quarterly metabolic bloodwork to track HbA1c, ApoB, fasting insulin, and lipids.
Semaglutide is a GLP-1 receptor agonist prescribed for weight management. Compounded and physician-prescribed at REVRCEL to a patient-specific prescription, with the same quarterly metabolic bloodwork integration.
This isn't for you if
- You're seeking medication without metabolic bloodwork.
- You have contraindications that disqualify GLP-1 therapy (assessed at intake).
Common questions
How are compounded GLP-1 medications dispensed?
They are prescribed by a licensed clinician and dispensed to a patient-specific prescription by licensed compounding pharmacies, titrated against bloodwork under physician oversight. They are not FDA-approved finished drug products.
Statements have not been evaluated by the FDA. Selections reflect REVRCEL's clinical formulary and do not constitute medical advice.
